BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25064846)

  • 1. The multifaceted regulation and functions of PKM2 in tumor progression.
    Li Z; Yang P; Li Z
    Biochim Biophys Acta; 2014 Dec; 1846(2):285-96. PubMed ID: 25064846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKM2 contributes to cancer metabolism.
    Wong N; Ojo D; Yan J; Tang D
    Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual roles of PKM2 in cancer metabolism.
    Wu S; Le H
    Acta Biochim Biophys Sin (Shanghai); 2013 Jan; 45(1):27-35. PubMed ID: 23212076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
    He Y; Wang Y; Liu H; Xu X; He S; Tang J; Huang Y; Miao X; Wu Y; Wang Q; Cheng C
    Leuk Res; 2015 Dec; 39(12):1428-36. PubMed ID: 26453405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.
    Zheng S; Liu Q; Liu T; Lu X
    J Physiol Biochem; 2021 Aug; 77(3):355-363. PubMed ID: 33835423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in PKM2 associate with prostate cancer progression.
    Wong N; Yan J; Ojo D; De Melo J; Cutz JC; Tang D
    Cancer Invest; 2014 Aug; 32(7):330-8. PubMed ID: 24884829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.
    Chen Z; Wang Z; Guo W; Zhang Z; Zhao F; Zhao Y; Jia D; Ding J; Wang H; Yao M; He X
    Oncogene; 2015 Jul; 34(30):3946-56. PubMed ID: 25263439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
    Li S; Ji X; Wang R; Miao Y
    Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
    Chaneton B; Gottlieb E
    Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
    Amin S; Yang P; Li Z
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
    Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of pyruvate kinase M2 associates with aggressive clinicopathological features and unfavorable prognosis in oral squamous cell carcinoma.
    Wang Y; Zhang X; Zhang Y; Zhu Y; Yuan C; Qi B; Zhang W; Wang D; Ding X; Wu H; Cheng J
    Cancer Biol Ther; 2015; 16(6):839-45. PubMed ID: 25970228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
    Dando I; Cordani M; Donadelli M
    IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation.
    Li T; Han J; Jia L; Hu X; Chen L; Wang Y
    Protein Cell; 2019 Aug; 10(8):583-594. PubMed ID: 30887444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into mechanisms for dynamic regulation of PKM2.
    Wang P; Sun C; Zhu T; Xu Y
    Protein Cell; 2015 Apr; 6(4):275-287. PubMed ID: 25645022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of PKM2 in cancer progression and its structural and biological basis.
    Wu B; Liang Z; Lan H; Teng X; Wang C
    J Physiol Biochem; 2024 May; 80(2):261-275. PubMed ID: 38329688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate DNA damage promotes metabolic flux into PPP via PKM2 Y-105 phosphorylation: a feature that favours cancer cells.
    Kumar B; Bamezai RN
    Mol Biol Rep; 2015 Aug; 42(8):1317-21. PubMed ID: 25840825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolism enzyme controls cancer stemness].
    Konno M; Doki Y; Mori M; Ishii H
    Nihon Rinsho; 2015 May; 73(5):745-50. PubMed ID: 25985625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells].
    Konno M; Hamabe A; Doki Y; Mori M; Ishii H
    Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging roles of PKM2 in cell metabolism and cancer progression.
    Luo W; Semenza GL
    Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.